Although the precise mechanisms of ALS pathogenesis have yet to be elucidated, Nogo, a representative myelin-associated inhibitor (MAI), and Nogo receptor-1 (NgR1) have recently attracted attention as molecules potentially implicated in ALS [1]. Here, RTN4 is linked to amyotrophic lateral sclerosis.